
|Articles|October 7, 2019
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
Author(s)Julianne Mobilian
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Advertisement
Denise Visco, MD, conducted a retrospective chart analysis of patients who received phenylephrine and ketorolac (OMIDRIA) during surgery-here's what she found.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ICYMI: AAO 2025 showcases new technologies and continued research
2
Evolving glaucoma therapy: A new era of interventional strategies
3
Q&A: William F. Wiley, MD, on what BVI's trifocal IOL approval means for US premium vision options
4
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
5

















































.png)


